Davies Award Case Study 3-5 page paper

Nicholas E. Davies Enterprise Award of Excellence Clinical Value Page 1 of 8 Applicant Organization: Centura Health Organization’s Address: 188 Inverness Dr . W #500, Englewood, CO 80112 Submitter: Amy Feaster, Vice President of Information Technology Email: [email protected] Core Item: Clinical Value Executive Summary Centura Health, founded in 1996, manages the assets of two sponsors under a joint operating agreement. For more than 100 years, Centura Health hospitals and services have been helping people to live healthier, longer lives. Our sponsors, Catholic Health Initiatives and Adventist Health System, have long provided compassionate, leading -edge care to those in need throughout the region. Our m ission is to extend the healing ministry of Christ by caring for those who are ill and by nurturing the health of the people in our communities. Centura Health is focused on providing affordable, world -class care through an integrated network in Colorado and Western Kansas. Over 17,000 of the best hearts and minds in medicine, along with 6,000 physician partners, serve more than one million patients each year. In 2007 we saw the potential to integrate several clinical systems into a common, secure Electro nic Health Record (EHR) system to make patient health information available across all Centura Health facilities while preserving patient privacy and information security. Centura’s EHR currently contains approximately 2.4 million patient records making it the largest integrated health network in the region. Centura Health’s implementation of a single, standardized EHR system successfully connected 15 hospitals, as well as numerous ambulatory, home health, hospice and urgent care clinics across Colorado an d Kansas. The goal is to allow seamless access to patient data through an integrated record in all clinical settings. Centura Health successfully reduced hospital acquired conditions and medication errors while increasing patient satisfaction. Clinical sta ff can now review patient -specific information even before arrival of the patient. Both historical and real time data are available for viewing and clinicians across the care continuum have access to the same patient record and best practice tools that support the highest standards of care. Our commitment to a single patient record across the entire system of care has led to increased coordination of efforts in unexpected areas. An example is our decision to extend the dyad leadership model, which is we ll established at Centura, beyond the typical clinical operations to include a dyad responsible for both clinical and operational aspects of supply chain management. This dyad consists of a facility CMO and the system VP of Supply Chain. We find enormous v alue in this model, and describe our success with blood product management in this context. Using the dyad leadership of supply chain and medical to design and institute a Nicholas E. Davies Enterprise Award of Excellence Clinical Value Page 2 of 8 multipronged blood products management program, we leveraged our EHR to change behav ior around packed red cell utilization, leading to a 58% reduction in units of blood transfused compared to the baseline year and a two year cost avoidance of approximately $1, 500 ,000. Blood Product Management Initiative Local Problem being Addressed and Intended Improvement Centura facilities and the system as a whole had attempted several times to address blood product management in the past. However, n o project had been truly successful or sustainable. With our dyad partnership in place, the CMO could b ring to his colleagues convincing evidence that Centura facilities were purchasing more blood than others in our market, and more than our sponsor systems predicted based on hospitals with similar service and size. Our VP of Supply Chain participated in ev ery discussion with the medical leadership and committed resources to supporting an initiative to change our processes and our clinical behavior. We embarked upon a blood product management initiative in 2013 which included address ing the clinical decision making around the use of packed red blood cells in our facilities. At that time, 7.5% of admitted patients received a blood transfusion, and each patient received an average of 2.96 units. To address this, we set a goal during fiscal year 2013 to utilize a massive t ransfusion protocol and embark on a system -wide educa tional campaign to bring ED transfusion practices in line with currently accepted guidelines. In 2014 , we embarked on a similar project targeting non -trauma , non -emergency rel ated blood utilization. We viewed this as an opportunity to utilize our EHR in a manner that would benefit our patients and clinicians, while at the same time properly managing the use of this very precious resource. Design and Implementation Our clinica l content development process is governed by a multidisci plinary team comprised of physicians, nurses, informaticists, pharmacists, information technology, and quality and safety leaders . This team meets with the clinical and operational leaders who want t o effect change in clinical behavior in order to work out each detail of the EHR support for the clinical change project. In this instance, the content management team worked with the trauma and ED directors to sift through available options in adjusting the EHR and ch ose the best fit for the problem being addressed. In 2013 , our t rauma service li ne directors developed a system -wide consensus on utilization of pRBC during trauma resuscitation. Our E D Directors agreed on a standardized approach to transfusion in non -trauma emergency cases. Acknowledging that these resuscitations are quite fast paced and generally the physician does not spend a lot of time at a computer in the midst of these situations , it was felt that a standard ED transfusion order set, if written well, could facilitate appropriate use of blood products during ED resuscitation. This order set was written and put into production in mid -2013 . All other avenues to order transfusions in the ED were removed from the EHR at that time. To address non -trauma blood product utilization , in 2014 we convened a group of subject matter experts (including blood bank experts, pathologists, hospitalists, orthopedic surgeons, Nicholas E. Davies Enterprise Award of Excellence Clinical Value Page 3 of 8 trauma surgeons, and ED physicians ) to develop guidelines for safe and appropriate use of pRBCs in non -trauma , non -ED situations, and developed an education campaign for our medical staffs. We confined transfusion ordering to an order set, fixed the quantity to default to one uni t, and instituted a new decision support rule in our EHR to support our new guidelines . However, t hese guidelines had to include a unique aspect that acknowledged the fact that we deliver medical care in some locations that are at elevations above 6500 ft. Only with our ability to acknowledge and validate the medical decisions that are made for transfusion targets at high elevatio ns were we able to reach system -wide consensus on implementation of this new decision support pathway. The following are identif ied as generally accepted thresholds for transfusion of pRBCs at Centura Health:  HGB less than or equal to 7 g/dL  Acute blood loss: > 20% Estimated Blood Volume  Hematologic or oncologic diagnosis  Hgb 7 -10 g/dL WITH underlying disease that could cause tissue hypoxia (Acute MI, CVA, CHF, COPD for example)  Elevation > 6,500 ft When pRBC transfusion is ordered and the most recent hemoglobin is greater than 7.0 g/dL, the ordering provider will be asked to indicate the reason for transfusion. Also, it is re commended that only one unit of packed red cells be transfused unless the patient is actively bleeding or in an emergency situation so that the hemoglobin and clinical situation can be re -evaluated to determine the need for additional units. The intended outcome of this 2 -year long project was to ensure that we are using this precious resource in clinically appropriate situations and not putting our patients at unnecessary risk by transfusing blood when other means of treatment may be more appropriate. Ho w was Health IT Utilized? Changes made in the EHR included:  W e restricted the ability to order a blood transfusion to an order set.  For the ED order set , we specified the quantity for each blood product to speed order entry. Nicholas E. Davies Enterprise Award of Excellence Clinical Value Page 4 of 8  For the inpatient transfusion order set, we defaulted the number of pRBC units to transfuse to one.  For non -trauma patients, we instituted a rule that checks that most recent hemoglobin, looking back 72 hours across encounters. If the most recent hemoglobi n was 7.0 or greater , the ordering provider receives the following warning: Nicholas E. Davies Enterprise Award of Excellence Clinical Value Page 5 of 8 Override reasons include one of high elevation of the treatment site or of the patient’s home address, in addition to other clinically appropriate reasons for an override. We d eveloped education regarding clinical indications for transfusion including the more restrictive hemoglobin threshold now accepted as reasonable, the ‘new’ principle of transfusing the least amount needed, and introducing the alert described above. This ed ucation was presented to each of the 15 hospitals medical staffs via meetings, conferences and existing local communication methods. Value Derived/Outcomes Since the inception of the project we have experienced a 58 percent decrease in the utilization of pRBCs compared to 2012 . In 2013 , 7.5 percent of our admitted patients received transfusions , whereas in 2015 only 6.2 percent received transfusions. This constitutes 2,328 patients who were spared the risks of blood administration as a result of this effort. Additionally, in 2013 our units/patient ratio was 2.96. In 2015 this was reduced to 2.74. All facilities have shown a decrease in both the number of units transfused and the number of patients who received transfusion , despite an overall growth in number of patients treated in our system. Because transfusion reactions and adverse events are relatively rare and there is poor consensus on incidence, it is difficult to quantify the avoidance of adverse events for patients.

Howeve r, conservatively, we may have avoided 23 acute febrile reactions, 4 cases of TRALI and one case of TACO. BBGuy.org Reaction Summary Chart; © 2012, Joe Chaffin, MD Given a cost of $225/unit of pRBC, $40/unit processing cost (does not include complex antib ody processing, or nursing administration), and 6 ,542 avoided units, we estimate our two year cost savings to be approximately $1 .5 million . This change in clinical decision making required approximately 6 months of clinical expert meetings, four months of educational ef fort and two changes in our EHR. Although our clinical pathology colleagues had worked to change behavior in this area for several years prior, the key factors to the success of this attempt was the involvement of our supply chain colleagues and our newly functional EHR content management process. Nicholas E. Davies Enterprise Award of Excellence Clinical Value Page 6 of 8 28,478 20,999 18,773 18,038 0 5,000 10,000 15,000 20,000 25,000 30,000 FY 2012 FY 2013 FY 2014 FY 2015 Units Total units pRBC transfused 10,094 7,133 6,575 6,186 0 2,000 4,000 6,000 8,000 10,000 12,000 FY 2012 FY 2013 FY 2014 FY 2015 Patients Total patients who received pRBC transfusion Nicholas E. Davies Enterprise Award of Excellence Clinical Value Page 7 of 8 Lessons Learned This project succeeded because our content management process developed strong support from physician s, blood bank s, supply chain and analytics. The key difference was the involvement of our sup ply chain experts who brought an area of expertise to the table that had previously been untapped . These experts were essential in bringing our blood product vendors into the discussions so that we could better understand the supply chain from donation to administration. Their involvement also provided us with comparative data and Centura -specific purc hase and waste data that was needed to signify the importance of this project. The creation of the dyad leadership model between supply chain and medical leadership has been invaluable in our successful execution. Dividing the massive topic of blood p rodu ct utilization into smaller segments by asking the trauma experts to work together and address their needs, then sequentially asking the ED, then non -trauma medical experts to follow suit , was done as a practical matter ori ginally , but in the end was seen as a smart method to slowly address the culture change that was needed. Discussions with involved or affecte d physicians in one group cross -pollinated the other groups, so that the non -trauma change management was quite minimal. Financial Considerations Th is project required considerable effort in the form of hours of clinical expertise in meetings, and development of new reports from our clinical and financial databases. Our clinical content governance matured through the two years of this project, and FTEs were added to the content management team, including reimbursed subject matter expert time. This contributed to our ability to execute on sch edule. The creation of a system wide laboratory directorship and presence of a ful l-time blood bank monitor role also contributed to the success of the project . These new expenditures were negotiated into our routine budgeting process. This included approximately 200 hours on the part of a multidisciplinary team (physician, blood bank, lab, Nicholas E. Davies Enterprise Award of Excellence Clinical Value Page 8 of 8 trauma, nurse, IT, supply chain) for consensus building and design of intervention and education , and about $11,000 in IT cost for content and report development.